NCT01086761View on ClinicalTrials.gov

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

PHASE1TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Wet Age-Related Macular Degeneration
Interventions
BIOLOGICAL

MP0112

Single intravitreal injection of MP0112 in the study eye.

Trial Locations (8)

13008

Centre Paradis-Monticelli, Marseille

16902

Ustrendi Vojenska Nemocnice, Prague

62500

Fakultni Nemocnice Brno, Brno

67091

Hopitaux Universitaires, Strasbourg

69003

Centre Rabelais, Lyon

77520

Fakultni Nemocnice Olomouc, Olomouc

94010

Hopital Intercommunual de Creteil, Créteil

CH-3010

Inselspital, Bern

Sponsors

Lead Sponsor

Allergan

Collaborators (1)

Molecular Partners AG
All Listed Sponsors
collaborator

Molecular Partners AG

INDUSTRY

lead

Allergan

INDUSTRY

NCT01086761 - Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration | Biotech Hunter | Biotech Hunter